Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk
Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome
Single Ascending and Multiple-Dose Trial of Zerlasiran, a Short Interfering RNA Targeting Lipoprotein(a): A Randomized Clinical Trial
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia
Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia: The SHASTA-2 Randomized Clinical Trial
Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia
